ReviewCurrent atherosclerosis reports2025

Quo Vadis after AEGIS: New Opportunities for Therapies Targeted at Reverse Cholesterol Transport?

Nick S R Lan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.